We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.74B
AUM Growth
-$335M
Cap. Flow
-$614M
Cap. Flow %
-16.42%
Top 10 Hldgs %
21.69%
Holding
674
New
53
Increased
215
Reduced
238
Closed
121

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$107M
2
AAPL icon
Apple
AAPL
+$71.8M
3
TRV icon
Travelers Companies
TRV
+$27.6M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$27.4M
5
AXP icon
American Express
AXP
+$26.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.7%
2 Financials 10.88%
3 Technology 9.76%
4 Communication Services 9.34%
5 Consumer Staples 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
26
Merck
MRK
$324B
$29.3M 0.78%
581,553
-169,750
-23% -$8.56M
FSLR icon
27
First Solar
FSLR
$21.8B
$29.2M 0.78%
442,323
-117,454
-21% -$6.58M
ESRX
28
DELISTED
Express Scripts Holding Company
ESRX
$28.2M 0.76%
323,179
+117,349
+57% +$10.1M
GOOG icon
29
Alphabet (Google) Class C
GOOG
$3.9T
$26.7M 0.72%
+704,520
New +$25.3M
GE icon
30
GE Aerospace
GE
$367B
$26.2M 0.7%
175,301
-14,629
-8% -$2.08M
JPM icon
31
JPMorgan Chase
JPM
$939B
$25.2M 0.68%
382,355
+97,243
+34% +$6.33M
DFS
32
DELISTED
Discover Financial Services
DFS
$25.1M 0.67%
467,783
+277,376
+146% +$15.4M
WY icon
33
Weyerhaeuser
WY
$17.3B
$24.2M 0.65%
808,669
-11,802
-1% -$356K
KO icon
34
Coca-Cola
KO
$354B
$23.8M 0.64%
553,463
-207,823
-27% -$8.82M
BMRN icon
35
BioMarin Pharmaceuticals
BMRN
$11.5B
$23.5M 0.63%
224,279
+117
+0.1% +$12.2K
QCOM icon
36
Qualcomm
QCOM
$176B
$21.9M 0.59%
438,819
-202,960
-32% -$10.8M
MNST icon
37
Monster Beverage
MNST
$91.4B
$21.9M 0.59%
883,374
+275,472
+45% +$6.65M
HBAN icon
38
Huntington Bancshares
HBAN
$35.1B
$21.7M 0.58%
1,964,988
-84,110
-4% -$940K
NVDA icon
39
NVIDIA
NVDA
$5.01T
$21.5M 0.58%
26,139,960
-15,322,560
-37% -$11.5M
CBRE icon
40
CBRE Group
CBRE
$40.8B
$21.5M 0.58%
622,200
-32,939
-5% -$1.16M
C icon
41
Citigroup
C
$222B
$20M 0.54%
386,730
+129,669
+50% +$6.88M
AIZ icon
42
Assurant
AIZ
$13.7B
$20M 0.53%
247,942
-53,592
-18% -$4.42M
KEY icon
43
KeyCorp
KEY
$24.3B
$19.8M 0.53%
1,497,624
-266,257
-15% -$3.49M
MMM icon
44
3M
MMM
$89B
$19.7M 0.53%
156,255
-72,667
-32% -$9.34M
WFC icon
45
Wells Fargo
WFC
$261B
$19.3M 0.52%
354,596
-19,649
-5% -$1.07M
PYPL icon
46
PayPal
PYPL
$49.5B
$18.9M 0.5%
520,790
+164,542
+46% +$5.8M
STJ
47
DELISTED
St Jude Medical
STJ
$18.6M 0.5%
301,391
+99,154
+49% +$6.25M
CTXS
48
DELISTED
Citrix Systems Inc
CTXS
$18.4M 0.49%
305,345
+289,099
+1,780% +$17.8M
YHOO
49
DELISTED
Yahoo Inc
YHOO
$18.2M 0.49%
545,921
-270,380
-33% -$9.02M
SLB icon
50
SLB Ltd
SLB
$77.8B
$17.2M 0.46%
246,860
+72,959
+42% +$5.46M

Similar funds

Candriam SCA's Q4 2015 Portfolio in Review

As of Q4 2015, Candriam SCA held 674 positions worth $3.74B, down 8.2% from $4.07B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA withdrew a net $614M in Q4 2015, closing 121 positions and reducing 238 holdings. Its most notable exit was Amgen, an estimated $107M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in Alphabet (Google) Class A worth $118M.

  • Candriam SCA's largest Q4 2015 buy was Alphabet (Google) Class A: 3,043,280 shares worth $118M.
  • Candriam SCA added most to Intel in Q4 2015, an estimated $61.2M increase.
  • Candriam SCA's biggest Q4 2015 reduction was Colgate-Palmolive, cutting an estimated $21.3M.
  • Candriam SCA fully exited Amgen in Q4 2015, selling an estimated $107M.
  • Candriam SCA's ten largest holdings make up 22% of its $3.74B portfolio in Q4 2015.
  • Candriam SCA opened 53 new positions and closed 121 in Q4 2015.
  • Candriam SCA's portfolio value fell 8.2% quarter-over-quarter to $3.74B.

Based on Candriam SCA's 13F filing for Q4 2015, filed 25 Jan 2016.